Anticipating Drug Pricing Plans from the Trump Administration

Two of the top pharmaceutical executives’ Jose Jimenez, CEO Novartis and Brent Saunders, CEO of AllerganPlc, anticipate proposals from the Trump administration within the next few weeks to address the high cost of drugs. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.